Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt

gan Chan, Anita Y. M., Dolinsky, Vernon W., Soltys, Carrie-Lynn M., Viollet, Benoit, Baksh, Shairaz, Light, Peter E., Dyck, Jason R. B.
Cyhoeddwyd 2008

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes

gan Matsumura, Nobutoshi, Zordoky, Beshay N, Robertson, Ian M, Hamza, Shereen M, Parajuli, Nirmal, Soltys, Carrie-Lynn M, Beker, Donna L, Grant, Marianne K, Razzoli, Maria, Bartolomucci, Alessandro, Dyck, Jason R B
Cyhoeddwyd yn Cardiovasc Res (2018)